Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microalbuminuria: prognostic implications

G L Bakris1

  • 1Rush University Hypertension Center, Rush Presbyterian/St. Luke's Medical Center, Chicago, IL 60612, USA.

Current Opinion in Nephrology and Hypertension
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hyperkalaemia in diabetes: a silent risk predicting poor outcomes.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

Renal Targeted Therapies of Antihypertensive and Cardiovascular Drugs for Patients With Stages 3 Through 5d Kidney Disease.

Clinical pharmacology and therapeutics·2017
Same author

Masked and Nocturnal Hypertension in the ARTS-DN ABPM Sub-Study with Finerenone.

Journal of the American Society of Hypertension : JASH·2016
Same author

The Effects of Nebivolol-Valsartan Single-Pill Combinations in Reducing Blood Pressure in Patients with Stage I or II Hypertension.

Journal of the American Society of Hypertension : JASH·2016
Same author

The Medical Bookshelf.

Postgraduate medicine·2016
Same author

Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies.

Clinical pharmacology and therapeutics·2014
Same journal

Updates in management of cardiorenal syndrome.

Current opinion in nephrology and hypertension·2026
Same journal

Sex differences in renal acid-base regulation.

Current opinion in nephrology and hypertension·2026
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
See all related articles

Microalbuminuria, an early sign of kidney damage, is a significant risk factor for kidney and cardiovascular mortality in diabetic patients. Annual screening is recommended for all individuals with diabetes.

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiology

Background:

  • Microalbuminuria indicates albumin in urine, exceeding normal levels but below conventional dipstick detection.
  • Its prognostic significance as an indicator of renal and cardiovascular risk is increasingly recognized.
  • It is linked to various renal and non-renal diseases.

Purpose of the Study:

  • To evaluate the prognostic value of microalbuminuria in diabetic and non-diabetic subjects.
  • To assess its role as a risk factor for renal and cardiovascular mortality.
  • To determine the utility of screening for microalbuminuria in different patient populations.

Main Methods:

  • Review of existing data and studies on microalbuminuria.
  • Analysis of its association with mortality in diabetic and hypertensive patients.

Related Experiment Videos

  • Evaluation of intervention strategies for managing microalbuminuria.

    • Main Results:

    • Microalbuminuria is an independent risk factor for renal mortality in insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM).
    • It is associated with a 4-6 fold increase in cardiovascular mortality in diabetic subjects.
    • In non-diabetic hypertensive subjects, it reflects injury from elevated blood pressure rather than being an independent risk factor.

    Conclusions:

    • Annual assessment of microalbuminuria is recommended for all diabetic patients.
    • Early intervention, including blood glucose control and ACE inhibitors, can attenuate microalbuminuria and nephropathy progression in diabetics.
    • Routine screening in hypertensive non-diabetic subjects is not currently recommended.